Categories: News

Inogen to Announce Second Quarter 2021 Financial Results on August 4, 2021

GOLETA, Calif.–(BUSINESS WIRE)–Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2021 financial results after market close on Wednesday, August 4, 2021. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.

Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic callers or (201) 689-8589 for international callers. Please reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen’s website at: http://investor.inogen.com/.

A replay of the call will be available beginning August 4, 2021 at 3:30pm PT/6:30pm ET through 3:30pm PT/6:30pm ET on August 18, 2021. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Conference ID: 13721387. The webcast will also be available on Inogen’s website for one year following the completion of the call.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

We are a medical technology company offering innovative respiratory products for use in the homecare setting. We primarily develop, manufacture and market innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

Contacts

Investor Relations & Media Contact:
Ali Bauerlein

ir@inogen.net

Staff

Recent Posts

Tersis Technologies Announces Strategic Initiatives Designed to Address Global Environmental and Economic Pressures

Brooksville, Florida--(Newsfile Corp. - December 18, 2025) - Tersis Technologies (OTCID: TERS) ("Tersis"), now trading…

1 hour ago

Edison Issues Report on MindMaze Therapeutics (MMTX)

London, United Kingdom--(Newsfile Corp. - December 18, 2025) - Edison issues report on MindMaze Therapeutics…

1 hour ago

Coloplast announces changes to Executive Leadership Team

Today, Coloplast is announcing changes to the company’s Executive Leadership Team (ELT). The changes relate…

2 hours ago

Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference

- The overview presentation will review some of the Company’s recent achievements as well as…

2 hours ago

ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK

Peak Medical, ENvue’s Exclusive Distributor in UK, Places Significant Order after Reimbursement Decision, Projecting Future…

2 hours ago